Evan Walker, MD

Safety and preliminary efficacy of ivaltinostat, an HDAC inhibitor, plus capecitabine in patients with pretreated metastatic pancreatic adenocarcinoma (mPDAC): Results of a phase Ib study.

Journal of Clinical Oncology

Christos Fountzilas, Andrew H. Ko, Erkut Hasan Borazanci, James Thomas D'Olimpio, Joel R Hecht, Shou-Ching Tang, Anthony F. Shields, Mohamad Adham Salkeni, glenn C michelson, Lorna Liganor, Gene Cho, Sangsook Ahn Cho, Evan Justin Walker

An Exercise in Clinical Reasoning: Use of Social Context in Diagnosing an Elevated Lactate.

Journal of general internal medicine

Chang RS, Ow GM, Walker EJ, Brooks K, Lai AR

Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC): A mixed-methods study.

Journal of Clinical Oncology

Daniel H Kwon, Marissa McPhaul, Saffanat Sumra, Carling Jade Ursem, Evan Justin Walker, Maren Theresa Scheuner, Sunny Wang, Rahul Raj Aggarwal, Franklin W. Huang, Jeffrey Belkora

A randomized, multi-center, phase 2 study of ivaltinostat (Ival) plus capecitabine (Cape) versus capecitabine alone in the maintenance setting in patients with metastatic pancreatic adenocarcinoma (mPDAC).

Journal of Clinical Oncology

Christos Fountzilas, Andrew H. Ko, Erkut Hasan Borazanci, James Thomas D'Olimpio, J. Randolph Hecht, Shou-Ching Tang, Anthony F. Shields, Mohamad Adham Salkeni, Glenn Michelson, Gene Cho, Lorna Liganor, Sangsook Ahn Cho, Evan Justin Walker

Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC).

Journal of Clinical Oncology

Daniel H Kwon, Marissa McPhaul, Eliza Hearst, Saffanat Sumra, Carling Jade Ursem, Evan Justin Walker, Maren Theresa Scheuner, Sunny Wang, Rahul Raj Aggarwal, Franklin W. Huang, Jeffrey Belkora

Results of the safety and tolerability of ivaltinostat plus capecitabine in the phase 1b portion of a phase 1b/2, dose-escalation, randomized, multi-center study in the maintenance (maint) setting in patients with metastatic pancreatic adenocarcinoma (mPD

Journal of Clinical Oncology

Evan Justin Walker, Christos Fountzilas, Erkut Hasan Borazanci, Anthony F. Shields, James Thomas D'Olimpio, J. Randolph Hecht, Shou-Ching Tang, Glenn Michelson, Lorna Liganor, Sangsook Ahn Cho, Andrew H. Ko

Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity.

Cancers

Walker EJ, Ko AH

A phase 1b/2, dose-escalation, randomized, multicenter study of maintenance (maint) ivaltinostat (ival) plus capecitabine (cap) or capecitabine monotherapy in patients (pts) with metastatic pancreatic adenocarcinoma (PDAC) whose disease has not progressed

Journal of Clinical Oncology

Evan Justin Walker, Erkut Hasan Borazanci, Gehan Botrus, Christos Fountzilas, J. Randolph Hecht, Anup Kasi, Niharika B. Mettu, Shubham Pant, Glenn Michelson, Gene Cho, Sangsook Ahn Cho, Lorna Liganor, Andrew H. Ko

The Gut Microbiome in Colorectal Cancer.

Hematology/oncology clinics of North America

Piawah S, Walker EJ, Van Blarigan EL, Atreya CE

The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.

Pancreas

Walker EJ, Blanco AM, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH

The VA My Life My Story Project: Keeping Medical Students and Veterans Socially Connected While Physically Distanced.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS

Walker E, Bruns E, Dhaliwal G

Implementation of an embedded in-clinic genetic testing station to optimize germline testing for patients with pancreatic adenocarcinoma.

The oncologist

Walker EJ, Goldberg D, Gordon KM, Pedley C, Carnevale J, Cinar P, Collisson EA, Tempero MA, Ko AH, Blanco AM, Dhawan M

Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair deficient pancreatic cancer.

Immunotherapy

Tsang ES, Walker EJ, Carnevale J, Fisher GA, Ko AH

Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.

Journal of Clinical Oncology

Evan Justin Walker, Sorbarikor Piawah, Ann Griffin, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Margaret A. Tempero, Andrew H. Ko

Anxious, Depressed, and Planning for the Future: Advance Care Planning in Diverse Older Adults.

Journal of the American Geriatrics Society

McMahan RD, Barnes DE, Ritchie CS, Jin C, Shi Y, David D, Walker EJ, Tang VL, Sudore RL

Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series.

Anticancer research

Gonzalez A, Walker EJ, Van Loon K, Cinar P, Atreya CE

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

Familial cancer

Walker EJ, Carnevale J, Pedley C, Blanco A, Chan S, Collisson EA, Tempero MA, Ko AH

A Protean Protein.

Journal of hospital medicine

Nawas MT, Walker EJ, Richie MB, White AA, Hsu G

Interprofessional primary care electronic intervention to reduce hypoglycaemic agent use in high-risk veterans with diabetes.

BMJ open quality

Upadhyay V, Walker E, Govea A, Rife T, Jimenez I, Dulay M, Beaman J

Advance Care Planning Documentation Practices and Accessibility in the Electronic Health Record: Implications for Patient Safety.

Journal of pain and symptom management

Walker E, McMahan R, Barnes D, Katen M, Lamas D, Sudore R

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.

Pancreas

Ko AH, LoConte N, Tempero MA, Walker EJ, Kate Kelley R, Lewis S, Chang WC, Kantoff E, Vannier MW, Catenacci DV, Venook AP, Kindler HL

Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.

Cancer

Walker EJ, Ko AH, Holly EA, Bracci PM

A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Journal of gastrointestinal oncology

Walker EJ, Simko JP, Nakakura EK, Ko AH

Abstract 2160: Metformin use is not associated with pancreatic cancer risk in a clinic-based case-control study conducted in the San Francisco Bay Area, California.

Epidemiology

Evan J. Walker, Andrew H. Ko, Elizabeth A. Holly, Paige M. Bracci

Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.

PloS one

Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M

Abstract 1933: Preferential ubiquitination of hypoxia-inducible factors depends on the SxxSS motif in human T-cell factor-4 isoforms derived from hepatocellular carcinoma.

Cancer research

Hironori Koga, Evan J. Walker, Orkhontuya Tsedensodnom, Jack R. Wands, Miran Kim

Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.

Forum on immunopathological diseases and therapeutics

Walker EJ, Rosenberg SA, Wands JR, Kim M

Abstract 4067: A T-cell factor-4 motif regulates the phenotype of hepatocellular carcinoma cells.

Cancer research

Hironori Koga, Evan J. Walker, Orkhontuya Tsedensodnom, Jack R. Wands, Miran Kim

Low density contrast agents for x-ray phase contrast imaging: the use of ambient air for x-ray angiography of excised murine liver tissue.

Physics in medicine and biology

Laperle CM, Hamilton TJ, Wintermeyer P, Walker EJ, Shi D, Anastasio MA, Derdak Z, Wands JR, Diebold G, Rose-Petruck C

Publications

Safety and preliminary efficacy of ivaltinostat, an HDAC inhibitor, plus capecitabine in patients with pretreated metastatic pancreatic adenocarcinoma (mPDAC): Results of a phase Ib study.

An Exercise in Clinical Reasoning: Use of Social Context in Diagnosing an Elevated Lactate.

Informed decision-making about germline testing among Veterans with advanced prostate cancer (APC): A mixed-methods study.

A randomized, multi-center, phase 2 study of ivaltinostat (Ival) plus capecitabine (Cape) versus capecitabine alone in the maintenance setting in patients with metastatic pancreatic adenocarcinoma (mPDAC).

Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC).

Results of the safety and tolerability of ivaltinostat plus capecitabine in the phase 1b portion of a phase 1b/2, dose-escalation, randomized, multi-center study in the maintenance (maint) setting in patients with metastatic pancreatic adenocarcinoma (mPD

Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity.

A phase 1b/2, dose-escalation, randomized, multicenter study of maintenance (maint) ivaltinostat (ival) plus capecitabine (cap) or capecitabine monotherapy in patients (pts) with metastatic pancreatic adenocarcinoma (PDAC) whose disease has not progressed

The Gut Microbiome in Colorectal Cancer.

The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing.

The VA My Life My Story Project: Keeping Medical Students and Veterans Socially Connected While Physically Distanced.

Implementation of an embedded in-clinic genetic testing station to optimize germline testing for patients with pancreatic adenocarcinoma.

Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair deficient pancreatic cancer.

Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.

Anxious, Depressed, and Planning for the Future: Advance Care Planning in Diverse Older Adults.

Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series.

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.

A Protean Protein.

Interprofessional primary care electronic intervention to reduce hypoglycaemic agent use in high-risk veterans with diabetes.

Advance Care Planning Documentation Practices and Accessibility in the Electronic Health Record: Implications for Patient Safety.

A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma.

Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.

A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Abstract 2160: Metformin use is not associated with pancreatic cancer risk in a clinic-based case-control study conducted in the San Francisco Bay Area, California.

Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study.

Hepatitis B viral reactivation secondary to imatinib treatment in a patient with gastrointestinal stromal tumor.

Beyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options?

Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.

Abstract 1933: Preferential ubiquitination of hypoxia-inducible factors depends on the SxxSS motif in human T-cell factor-4 isoforms derived from hepatocellular carcinoma.

Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.

Abstract 4067: A T-cell factor-4 motif regulates the phenotype of hepatocellular carcinoma cells.

Low density contrast agents for x-ray phase contrast imaging: the use of ambient air for x-ray angiography of excised murine liver tissue.